Suppr超能文献

重症监护后一年生存率作为普通医学中预先医疗指示的决策依据:对149144例患者的真实数据进行分析

One-year survival after critical care as a decision basis for advance care directives in general medicine: Real word data analysis of 149,144 patients.

作者信息

Unger Constantin, Werner Felix, Engel Bettina, Kühlein Thomas, Schulz Christoph, Kümpel Christian, Gorkotte Johannes, Hueber Susann

机构信息

Allgemeinmedizinisches Institut, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

GWQ Service Plus AG, Düsseldorf, Germany.

出版信息

PLoS One. 2025 Jun 27;20(6):e0326031. doi: 10.1371/journal.pone.0326031. eCollection 2025.

Abstract

Providing counsel on advance care directives is challenging for general practitioners. Counselling is done on unknown future circumstances of possible critical illness and critical care in intensive care units. Following the principles of evidence-based medicine, the physician's task is to communicate evidence and elucidate the patient's position on it. However, suitable evidence of chances of survival in case of critical illness is lacking. Aim of this study was to generate long-term survival rates of patients receiving critical care as evidence for general practitioners who provide counselling for patients on advance care directives. We conducted a retrospective cohort study analysing one-year survival rates of critical care using German health insurance claims data from an anonymised nationwide health claims data pool of over five million German patients. All patients over 18 years of age receiving critical care for the first time were included.Main outcome of our study were one-year survival probabilities depending on age and on acute life prolonging procedures. Procedures analysed were non-invasive and invasive mechanical ventilation (nMV, iMV), renal replacement therapy (RRT), their combinations (nMV + RRT, iMV + RRT), and cardiopulmonary resuscitation (CPR). A total of 149,144 datasets was analysed. One-year survival probability of all patients was 77.5%. Survival rates ranged from 94.5% in patients under 50 without any further acute life prolonging procedures to 16.4% in those older than 80 who received iMV + RRT. The application of at least one procedure was associated with an increased risk of death (HR 3.06, 95% CI 2.99 to 3.12) as was CPR (HR 4.22, 95% CI 4.07 to 4.37). Differences between pre- and COVID periods were modest. To enable patient's decision-making in creating advance care directives, our results provide easily applicable external evidence for general practitioners counselling on advance care directives by providing probabilities of survival in critical care.

摘要

对全科医生来说,就预立医疗指示提供咨询具有挑战性。咨询是在对可能的危重病和重症监护病房的重症护理的未知未来情况进行的。遵循循证医学原则,医生的任务是传达证据并阐明患者对此的立场。然而,缺乏关于危重病患者生存几率的合适证据。本研究的目的是得出接受重症护理患者的长期生存率,作为为患者提供预立医疗指示咨询的全科医生的证据。我们进行了一项回顾性队列研究,使用来自一个匿名的全国性健康保险理赔数据库(超过500万德国患者)的德国健康保险理赔数据,分析重症护理的一年生存率。纳入所有首次接受重症护理的18岁以上患者。我们研究的主要结果是取决于年龄和急性生命延长程序的一年生存概率。分析的程序包括无创和有创机械通气(nMV、iMV)、肾脏替代治疗(RRT)、它们的组合(nMV + RRT、iMV + RRT)以及心肺复苏(CPR)。共分析了149,144个数据集。所有患者的一年生存概率为77.5%。生存率从50岁以下未接受任何进一步急性生命延长程序的患者中的94.5%到80岁以上接受iMV + RRT的患者中的16.4%不等。至少应用一种程序与死亡风险增加相关(HR 3.06,95% CI 2.99至3.12),心肺复苏也是如此(HR 4.22,95% CI 4.07至4.37)。疫情前和疫情期间的差异不大。为了使患者在制定预立医疗指示时能够做出决策,我们的结果通过提供重症护理中的生存概率,为就预立医疗指示提供咨询的全科医生提供了易于应用的外部证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b41/12204473/6ba726bed5da/pone.0326031.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验